Enalapril Articles
SYNERGY WITH ANTIHYPERTENSIVES
12 October 1992
SAVE STUDY CONFIRMS ACE INHIBITOR BENEFITS
7 September 1992
PLENDIL LAUNCHED IN GERMANY
7 September 1992
FALL IN PROFITS AT BANYU
22 June 1992
ZANTAC TOPS MAIL ORDER SALES IN USA
8 June 1992
ASTRA'S PLENDIL HEADING FOR CHF INDICATION
25 May 1992
STRATEGIES TO ACHIEVE CRITICAL MASS
20 April 1992
TEN YEARS OF ACE INHIBITION
23 March 1992
MS&D GREECE SALES RISE 19%
3 February 1992
GOOD 1991 RESULTS FOR MERCK AND FOREST LABS
3 February 1992
BANYU PINS HOPESON LIPOVAS
20 January 1992
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
